PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway

Jiayi Gu1, Zhiqi Zhang2, Tingyuan Lang3

  • 1Department of Gastrointestinal Surgery, Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai 200127, People's Republic of China.

Oncotargets and Therapy
|October 22, 2019
PubMed
Abstract

Insights

Protein tyrosine phosphatase, receptor type U (PTPRU) acts as a tumor suppressor by inhibiting cancer stemness. PTPRU attenuates the Hippo/YAP signaling pathway, impacting cancer development and prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Protein tyrosine phosphatase, receptor type U (PTPRU) is a key signaling molecule with largely unknown roles in cancer.
  • This study investigates the function of PTPRU in cancer development and its association with cancer stemness.

Purpose of the Study:

  • To elucidate the role of PTPRU in cancer, specifically its impact on cancer stemness.
  • To determine the molecular mechanisms by which PTPRU regulates cancer stemness, focusing on the Hippo/YAP signaling pathway.

Main Methods:

  • Analysis of PTPRU expression in colorectal and gastric cancer tissues and cell lines.
  • Functional assays including sphere formation, proliferation, and migration to assess cancer stemness.
  • Gene manipulation using lentivirus systems and molecular analyses (qRT-PCR, Western blot, luciferase reporter assays, ChIP-qPCR).
  • Statistical analyses including Kaplan-Meier and Spearman correlation.

Main Results:

  • PTPRU is downregulated in colorectal and gastric cancers and is associated with poor prognosis.
  • Overexpression of PTPRU reduces cancer stemness, while its knockdown enhances it.
  • PTPRU suppresses the Hippo/YAP signaling pathway by reducing YAP expression transcriptionally.
  • Restoration of YAP expression reverses the inhibitory effect of PTPRU on cancer stemness.

Conclusions:

  • PTPRU functions as a tumor suppressor by inhibiting cancer stemness.
  • The tumor-suppressive activity of PTPRU is mediated through the attenuation of the Hippo/YAP signaling pathway.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.2K